Evidence map›Paper›PMID 38949622›Full record

ArticleTherapeutic delivery2024

Quality-by-design-based microemulsion of disulfiram for repurposing in melanoma and breast cancer therapy.

Debadatta Mohapatra, Prakash Ch Senapati, Shantibhusan Senapati, Vivek Pandey, Pawan K Dubey, Sanjay Singh, Alakh N Sahu

Abstract read
In one paragraph

Article in Therapeutic delivery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Debadatta MohapatraPhytomedicine Research Laboratory, Department of Pharmaceutical Engineering & Technology, IIT (BHU), Varanasi- 221005, Uttar Pradesh, India.ORCID 0000-0003-3044-8706
Prakash Ch SenapatiIMT Pharmacy College, Gopalpur, Puri 752004, Odisha, India.ORCID 0000-0003-1832-2609
Shantibhusan SenapatiTumor Microenvironment & Animal Models Laboratory, Institute of Life Sciences, Bhubaneswar- 751023, Odisha, India.ORCID 0000-0001-7108-8255
Vivek PandeyCentre for Genetics Disorders, Institute of Science (BHU), Varanasi 221005, Uttar Pradesh, India.ORCID 0000-0002-1390-133X
Pawan K DubeyCentre for Genetics Disorders, Institute of Science (BHU), Varanasi 221005, Uttar Pradesh, India.ORCID 0000-0002-1438-3773
Sanjay SinghNanomedicine Research Laboratory, Department of Pharmaceutical Engineering & Technology, IIT (BHU), Varanasi- 221005, Uttar Pradesh, India.ORCID 0000-0002-6748-0585
Alakh N SahuPhytomedicine Research Laboratory, Department of Pharmaceutical Engineering & Technology, IIT (BHU), Varanasi- 221005, Uttar Pradesh, India.ORCID 0000-0002-2378-6179

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsDisulfiramDrug RepositioningEmulsionsAnimalsAntineoplastic AgentsCell Line, TumorCell SurvivalFemaleHumansMCF-7 CellsMelanomaMelanoma, ExperimentalMiceSolubilityAntineoplastic AgentsDisulfiramEmulsionsbreast cancercinnamon oildisulfiramd-optimal designformulationmelanomamicroemulsionquality-by-designrepurposingTween® 80

Identifiers

PMID38949622
PMCPMC11412148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.